EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ARIAD PHARMACEUTICALS was filed as Word mark on 07/20/2012 at the European Union Intellectual Property Office.
It was registered as a trademark on 02/06/2013.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 011059326 |
| Application date | July 20, 2012 |
| Publication date | October 30, 2012 |
| Entry date | February 6, 2013 |
| Expiration date | July 20, 2032 |
Trademark owner
40 Landsdowne Street
02139 Cambridge,
US
02139 Cambridge,
US
Trademark representatives
Steinstr. 20
40212 Düsseldorf
DE
goods and services
1
Preparations for detecting genetic aberrations for scientific purposes, including diagnostic, prognostic or treatment purposes; reagents, preparations and substances for the preparation or manufacture of pharmaceutical preparations for use in oncology, cardiovascular diseases (including stroke), ocular disorders, central nervous system diseases and disorders (including Alzheimer's and Parkinson's diseases), inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, organ transplant rejection and metabolic disorders, and devices, including stents; preparations for detecting genetic aberrations for scientific purposes; kits for detecting genetic predispositions for scientific purposes; reagents, preparations and substances for scientific purposes
5
Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular diseases (including stroke), ocular disorders, central nervous system diseases and disorders (including Alzheimer's and Parkinson's diseases), inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, organ transplant rejection and metabolic disorders; pharmaceutical preparations used in the treatment and/or prophylaxis of viral, pulmonary, genetic, renal, musculoskeletal, neurologic and gastrointestinal diseases; preparations for detecting genetic aberrations for medical purposes, including diagnostic, prognostic or treatment purposes; kits for detecting genetic predispositions for medical purposes; reagents, preparations and substances for medical purposes; reagents, preparations and substances for detecting cancer for healthcare professionals; preparations for detecting genetic aberrations for medical purposes, including diagnostic, prognostic or treatment purposes
9
Computer software for personalized medicine purposes including scientific analysis of gene sequences, electronic storage and retrieval of medical data and medical information for healthcare professionals; laboratory devices for detecting gene sequences
10
Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of cancer; medical diagnostic apparatus for detecting cancer or a predisposition to cancer; coatings sold as an integral component of medical stents and other implantable medical devices; stents
41
Educational classes, seminars, presentations and programs pertaining to cancer, pharmaceuticals, genetics, DNA analysis services, personalized medicine, cancer screening, diagnosis and treatment
42
Providing laboratory research services in the field of gene expression, namely, cancer biology; providing scientific information in the fields of pharmaceuticals and genetics; DNA analysis services; medical and scientific research in the field of pharmaceuticals, cancer treatment and diagnosis
44
Genetic testing and screening for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of cancer; providing medical information in the fields of pharmaceuticals and genetics; providing information in the field of cancer prevention, pharmaceuticals, screening, diagnosis and treatment
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 26, 2022 | Extension, Trade mark renewed | ||
| October 5, 2020 | Transfer / Change of address, Published | ||
| June 17, 2020 | Change Representative, Published | ||
| October 26, 2017 | Transfer / Change of address, Published | ||
| October 25, 2017 | Change Representative, Published | ||
| January 18, 2017 | Transfer / Change of address, Published | ||
| November 11, 2016 | Change Representative, Published |
ID: 11011059326